| Expression pattern: |
UP |
| Associated gene: |
DDIT4, S100B, Fbln2 |
| Associated microRNA: |
hsa-miR-103a-3p, hsa-miR-27a-3p, hsa-miR-200c-3p |
| Biological function: |
Potential diagnostic biomarker for MDD; suspected involvement in MDD neuroplasticity. |
| Molecular mechanism: |
May affect neuroplasticity through the ceRNA mechanism. |
| Biological pathway or process: |
ceRNA regulation (other); other pathway/process (other) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Can be used as diagnostic markers for MDD; ROC analysis indicated discrimination between MDD patients and healthy controls. |
| Description: |
hsa_circ_0113010 (also referred to as circEPB41) is up-regulated in peripheral blood of MDD patients and shows diagnostic potential by ROC analysis. Bioinformatics analysis suggests it may be involved in MDD neuroplasticity through a predicted ceRNA mechanism. |
| Confidence score: |
0.5047 |